04/23/2024
6:00 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
3:45 PM | Berenson Stephen (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:45 PM | Ausiello Dennis A (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:45 PM | Dere Willard H (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:45 PM | Fraser Claire (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:45 PM | Biondi Paul (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:45 PM | Kender Richard N (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/08/2024
3:45 PM | Graves Kurt (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:30 PM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
11:21 AM | BlackRock Inc. (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G/A | |
03/27/2024
3:20 PM | Seres Therapeutics (Issuer)
Thorell Marella (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
9:01 AM | Seres Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/05/2024
9:13 AM | Seres Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/05/2024
9:18 AM | Seres Therapeutics (Filer)
| Form DEF 14A | |
03/05/2024
6:05 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2024
6:06 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
8:48 PM | DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:42 PM | Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:21 PM | Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:29 PM | Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:31 PM | Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:13 PM | Arkowitz David (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:15 PM | Ege David S. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
11:23 AM | JANUS HENDERSON GROUP PLC (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G/A | |
01/30/2024
3:01 PM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G | |
01/10/2024
6:00 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
6:05 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
11:57 AM | FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G/A | |
11/02/2023
9:00 AM | Seres Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023
6:05 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2023
8:36 PM | Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
8:36 PM | Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
8:39 PM | Ege David S. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
8:39 PM | DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
8:39 PM | Arkowitz David (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
8:40 PM | Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
8:40 PM | Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
8:43 PM | Cloghessy Paula (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2023
6:00 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The Gold Grab of the Century (Ad) When central banks buy gold…
The rich buy right along with them.
And central banks are buying at breakneck pace.
Last year… 1,037 tons.
Just 45 tons less than the record set two years ago. That's why we have released our Free Precious Metals Investment Guide. |
08/15/2023
11:15 PM | Seres Therapeutics (Filer)
| Form EFFECT | |
08/08/2023
9:01 AM | Seres Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2023
6:05 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2023
7:00 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
4:29 PM | Ausiello Dennis A (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:35 PM | Biondi Paul (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:21 PM | Dere Willard H (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:21 PM | Kender Richard N (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:22 PM | Graves Kurt (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:24 PM | Behar Gregory (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:25 PM | Fraser Claire (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:25 PM | Berenson Stephen (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:05 PM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
9:16 AM | FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G/A | |
05/09/2023
9:00 AM | Seres Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2023
7:16 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2023
3:41 PM | Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2023
3:43 PM | Arkowitz David (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/27/2023
6:26 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
